Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine vs Tadalafil vs Combination in Erectile Dysfunction
NCT06947265Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of arginine and tadalafil in erectile dysfunction (ED) (3 arms), sponsored by Fayoum University Hospital. Primary endpoint: Sexual Health Inventory for Men at 8 weeks. Started Jan 2024; status: completed.
02
Drugs
argininetadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06947265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06947265.